Terns Pharmaceuticals, Inc. (TERN)
52.95
0.00 (0.00%)
USD |
NASDAQ |
May 13, 16:00
Terns Pharmaceuticals Free Cash Flow : -82.18M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 14.12B |
| Corcept Therapeutics, Inc. | 119.79M |
| Eli Lilly & Co. | 10.37B |
| Bristol Myers Squibb Co. | 11.91B |
| Nektar Therapeutics | -203.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.08M |
| Cash from Investing (Quarterly) | -350.00M |
| Cash from Financing (Quarterly) | 743.12M |
| Free Cash Flow Per Share (Quarterly) | -0.1939 |
| Free Cash Flow to Equity (Quarterly) | -18.97M |
| Free Cash Flow to Firm (Quarterly) | -19.08M |
| Free Cash Flow Yield | -1.66% |